Sun Kim, CEO of AIGENDRUG,will give a talk at Imperial College London on July 4th. Recently, QS Quacquarelli Symonds, a leading global higher education evaluation institution, announced the QS World University Rankings for 2025, ranking Imperial College London second, reaffirming its position as one of the top universities globally. CEO Kim's lecture, titled "Modeling Gene-Gene Interactions for Drug Response Prediction and Biomarker Gene Discovery," is part of the "I-X Seminar series." The event will attract experts from various fields, including artificial intelligence and biotechnology, highlighting AI's potential applications.